ISRG, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects.
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $490.93, signifying a +1.38% move from its prior day's close.
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $476.69, indicating a -1.05% shift from the previous trading day.
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Wells Fargo 2024 Healthcare Conference September 5, 2024 9:30 AM ET Company Participants Brandon Lamm - Investor Relations Jamie Samath - Chief Financial Officer Conference Call Participants Larry Biegelsen - Medical Device Analyst, Wells Fargo Larry Biegelsen Good morning. Welcome back.
ISRG's shares gain on the back of strength in da Vinci surgical system.
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $481.73, representing a -0.35% change from its previous close.
Intuitive Surgical (NASDAQ: ISRG) has seen solid gains of over 80% from levels of around $270 in early January 2021 to nearly $500 now, vs. an increase of about 50% for the S&P 500 over this period.
Even as some sectors face uncertainty, healthcare spending is on the upswing. Industry powerhouse UnitedHealth Group is rising above its short-term challenges.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Against expectations of a growth slowdown, Intuitive Surgical's results have been strong in 2024, supported by robust procedure volumes and a solid da Vinci 5 launch. Intuitive Surgical's margins picked up in Q2, despite the scaling of da Vinci 5 sales. Margins will come under pressure in coming quarters though as additional costs begin to hit. Intuitive Surgical has a large competitive advantage and a long growth runway, but its valuation will make it difficult for the company to generate strong returns.
Different companies have responded to the bull market in a variety of ways. Intuitive Surgical has seen shares soar as procedure volume and revenue increase steadily.